MedTrace Logo

Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity

NCT01386073 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-06-14

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of FreshKote and Systane for the reduction of dry eye signs and symptoms.

Conditions

  • Dry Eye

Interventions

DRUG

FreshKote

Three times a day for three months

DRUG

Systane

three times a day for three months

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Principal Investigators

  • Jay Pepose, MD · Pepose Vision Institute

  • Mitch Jackson, MD · Jackson Eye, S.C

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01386073 on ClinicalTrials.gov